First Trust Advisors LP Ovid Therapeutics Inc. Transaction History

First Trust Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.69 - $3.31 $1,199 - $2,350	710 Added 0.89%	80,907 $174,000
Q1 2022 May 13, 2022	SELL	$2.65 - $3.49 $12,335 - $16,245	-4,655 Reduced 5.49%	80,197 $252,000
Q4 2021 Feb 08, 2022	BUY	$3.13 - $3.73 $33,246 - $39,620	10,622 Added 14.31%	84,852 $272,000
Q3 2021 Nov 15, 2021	SELL	$3.31 - $4.04 $118,994 - $145,238	-35,950 Reduced 32.63%	74,230 $249,000
Q2 2021 Aug 16, 2021	BUY	$3.3 - $4.49 $11,167 - $15,194	3,384 Added 3.17%	110,180 $431,000

Q1 2021 May 14, 2021	BUY	$2.42 - $4.47 $20,746 - $38,321	8,573 Added 8.73%	106,796 $429,000
Q4 2020 Feb 02, 2021	BUY	$2.28 - $6.84 $13,317 - $39,952	5,841 Added 6.32%	98,223 $227,000
Q3 2020 Nov 05, 2020	BUY	$5.39 - $8.24 $497,938 - $761,227	92,382 New	92,382 $530,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.